IL-1 receptor antagonist (IL-1Ra), when used to treat metastasis in mouse models, has shown a sudden decrease in tumor development, because of the inhibition of IL-1 action, while those mice that have low IL-1 were resistant to the development of metastasis experimentally [40]. The gene discussed is IL1A; the disease is neoplasm.